Virtu Financial LLC Invests $140,000 in Oscar Health, Inc. (NYSE:OSCR)

Virtu Financial LLC acquired a new stake in shares of Oscar Health, Inc. (NYSE:OSCRFree Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 10,393 shares of the company’s stock, valued at approximately $140,000.

Other institutional investors have also recently bought and sold shares of the company. Hennessy Advisors Inc. boosted its position in shares of Oscar Health by 550.3% during the fourth quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock worth $56,292,000 after buying an additional 3,544,300 shares during the period. JPMorgan Chase & Co. grew its holdings in shares of Oscar Health by 68.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company’s stock valued at $48,977,000 after acquiring an additional 938,742 shares in the last quarter. Glynn Capital Management LLC raised its holdings in Oscar Health by 42.7% during the fourth quarter. Glynn Capital Management LLC now owns 2,733,237 shares of the company’s stock worth $36,735,000 after acquiring an additional 817,518 shares in the last quarter. Soros Fund Management LLC bought a new position in Oscar Health in the third quarter valued at approximately $12,726,000. Finally, Raymond James Financial Inc. bought a new stake in shares of Oscar Health during the 4th quarter worth approximately $6,613,000. Institutional investors own 75.70% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. Jefferies Financial Group assumed coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 target price for the company. Wells Fargo & Company lowered shares of Oscar Health from an “overweight” rating to an “equal weight” rating and lowered their price target for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $20.21.

View Our Latest Analysis on OSCR

Oscar Health Trading Down 1.4 %

Shares of OSCR stock opened at $13.29 on Monday. Oscar Health, Inc. has a fifty-two week low of $12.43 and a fifty-two week high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The stock’s fifty day moving average price is $14.90 and its two-hundred day moving average price is $16.05. The company has a market cap of $3.33 billion, a PE ratio of -663.92 and a beta of 1.75.

Oscar Health (NYSE:OSCRGet Free Report) last issued its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Equities analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Oscar Health Company Profile

(Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Featured Stories

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCRFree Report).

Institutional Ownership by Quarter for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.